Back
Entera Bio Ltd. 10K Form
Sell
27
ENTX
Entera Bio Ltd.
Last Price:
$1.76
Seasonality Move:
-18.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ENTX News And Ratings
See the #1 stock for the next 7 days that we like better than ENTX
ENTX Financial Statistics
Sales & Book Value
| Annual Sales: | $181K |
|---|---|
| Cash Flow: | $-2.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.33 |
| Price / Book: | 5.3 |
Profitability
| EPS (TTM): | -0.24460 |
|---|---|
| Net Income (TTM): | $-10.8M |
| Gross Margin: | $9K |
| Return on Equity: | -81.18% |
| Return on Assets: | -71.11% |
Entera Bio Ltd. Earnings Forecast
Key Entera Bio Ltd. Financial Ratios
-
The Gross Profit Margin over the past 8 years for ENTX is 4.97%.
-
The Selling, General & Administrative Expenses for ENTX have been equal to 2,814.92% of Gross Profit Margin.
-
The Research & Development expenses have been 2,485.64% of Revenue.
-
The Net Earning history of ENTX is -5,271.27% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 6 years.
Entera Bio Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENTX |
| CUSIP: | M40527 |
| Website: | enterabio.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 10.83 |
| Quick Ratio: | 10.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ENTX Technical Analysis vs Fundamental Analysis
Sell
27
Entera Bio Ltd. (ENTX)
is a Sell
Is Entera Bio Ltd. a Buy or a Sell?
-
Entera Bio Ltd. stock is rated a SellThe current Entera Bio Ltd. [ENTX] share price is $1.88. The Score for ENTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.